Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9848
Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion
Kurusamy, Sathishkumar | Lopez-Maderuelo, Dolores CNIC | Little, Robert | Cadagan, David | Savage, Aaron M | Ihugba, Jude C | Baggott, Rhiannon R | Rowther, Farjana B | Martinez-Martinez, Sara CNIC | Gomez-del Arco, Pablo CNIC | Murcott, Clare | Wang, Weiguang | Francisco Nistal, J | Oceandy, Delvac | Neyses, Ludwig | Wilkinson, Robert N | Cartwright, Elizabeth J | Redondo, Juan Miguel CNIC | Armesilla, Angel Luis
J Mol Cell Cardiol. 2017; 109:38-47
AIMS: Ischaemic cardiovascular disease is a major cause of morbidity and mortality worldwide. Despite promising results from pre-clinical animal models, VEGF-based strategies for therapeutic angiogenesis have yet to achieve successful reperfusion of ischaemic tissues in patients. Failure to restore efficient VEGF activity in the ischaemic organ remains a major problem in current pro-angiogenic therapeutic approaches. Plasma membrane calcium ATPase 4 (PMCA4) negatively regulates VEGF-activated angiogenesis via inhibition of the calcineurin/NFAT signalling pathway. PMCA4 activity is inhibited by the small molecule aurintricarboxylic acid (ATA). We hypothesize that inhibition of PMCA4 with ATA might enhance VEGF-induced angiogenesis. METHODS AND RESULTS: We show that inhibition of PMCA4 with ATA in endothelial cells triggers a marked increase in VEGF-activated calcineurin/NFAT signalling that translates into a strong increase in endothelial cell motility and blood vessel formation. ATA enhances VEGF-induced calcineurin signalling by disrupting the interaction between PMCA4 and calcineurin at the endothelial-cell membrane. ATA concentrations at the nanomolar range, that efficiently inhibit PMCA4, had no deleterious effect on endothelial-cell viability or zebrafish embryonic development. However, high ATA concentrations at the micromolar level impaired endothelial cell viability and tubular morphogenesis, and were associated with toxicity in zebrafish embryos. In mice undergoing experimentally-induced hindlimb ischaemia, ATA treatment significantly increased the reperfusion of post-ischaemic limbs. CONCLUSIONS: Our study provides evidence for the therapeutic potential of targeting PMCA4 to improve VEGF-based pro-angiogenic interventions. This goal will require the development of refined, highly selective versions of ATA, or the identification of novel PMCA4 inhibitors.
ATA | Angiogenesis | Calcineurin/NFAT | PMCA4 | VEGF
Animals | Aurintricarboxylic Acid | Calcium-Transporting ATPases | Cell Membrane | Cell Movement | Human Umbilical Vein Endothelial Cells | Humans | Mice | Mice, Knockout | Neovascularization, Physiologic | Zebrafish | Zebrafish Proteins
Files in this item
- SelectiveInhibitionPlasmaMembr ...